LMCG Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.2M | Buy |
139,806
+3,312
| +2% | +$713K | 1.88% | 9 |
|
|
2026
Q1 | $29.7M | Sell |
136,494
-2,882
| -2% | -$639K | 1.77% | 11 |
|
|
2025
Q4 | $31.8M | Sell |
139,376
-3,864
| -3% | -$880K | 1.82% | 8 |
|
|
2025
Q3 | $33.2M | Sell |
143,240
-3,007
| -2% | -$612K | 1.95% | 8 |
|
|
2025
Q2 | $27.1M | Sell |
146,247
-16,540
| -10% | -$3.07M | 1.7% | 9 |
|
|
2025
Q1 | $34.1M | Sell |
162,787
-4,469
| -3% | -$869K | 2.26% | 6 |
|
|
2024
Q4 | $29.7M | Sell |
167,256
-4,592
| -3% | -$844K | 1.82% | 8 |
|
|
2024
Q3 | $33.9M | Sell |
171,848
-203
| -0.1% | -$37.9K | 2.04% | 6 |
|
|
2024
Q2 | $29.5M | Buy |
172,051
+3,155
| +2% | +$523K | 1.72% | 7 |
|
|
2024
Q1 | $30.8M | Sell |
168,896
-1,386
| -0.8% | -$239K | 1.81% | 6 |
|
|
2023
Q4 | $26.4M | Buy |
170,282
+2,983
| +2% | +$435K | 1.63% | 6 |
|
|
2023
Q3 | $24.9M | Sell |
167,299
-2,248
| -1% | -$330K | 1.68% | 6 |
|
|
2023
Q2 | $22.8M | Buy |
169,547
+23,315
| +16% | +$3.42M | 1.48% | 8 |
|
|
2023
Q1 | $23.3M | Sell |
146,232
-3,891
| -3% | -$595K | 1.55% | 6 |
|
|
2022
Q4 | $24.3M | Sell |
150,123
-1,978
| -1% | -$303K | 1.69% | 7 |
|
|
2022
Q3 | $20.4M | Sell |
152,101
-5,703
| -4% | -$818K | 1.49% | 8 |
|
|
2022
Q2 | $24.2M | Sell |
157,804
-1,720
| -1% | -$263K | 1.67% | 6 |
|
|
2022
Q1 | $25.9M | Buy |
+159,524
| New | +$23.2M | 1.5% | 8 |
|
|
2015
Q3 | $10.7M | Sell |
196,830
-1,995
| -1% | -$130K | 0.23% | 168 |
|
|
2015
Q2 | $13.4M | Sell |
198,825
-4,269
| -2% | -$279K | 0.29% | 122 |
|
|
2015
Q1 | $11.9M | Sell |
203,094
-2,746
| -1% | -$166K | 0.25% | 165 |
|
|
2014
Q4 | $13.5M | Sell |
205,840
-877
| -0.4% | -$55.3K | 0.29% | 131 |
|
|
2014
Q3 | $11.9M | Sell |
206,717
-1,758
| -0.8% | -$97.6K | 0.27% | 157 |
|
|
2014
Q2 | $11.8M | Sell |
208,475
-16,215
| -7% | -$851K | 0.25% | 160 |
|
|
2014
Q1 | $11.5M | Sell |
224,690
-3,090
| -1% | -$156K | 0.26% | 158 |
|
|
2013
Q4 | $12M | Sell |
227,780
-8,958
| -4% | -$440K | 0.26% | 157 |
|
|
2013
Q3 | $10.6M | Sell |
236,738
-9,242
| -4% | -$410K | 0.26% | 144 |
|
|
2013
Q2 | $10.2M | Buy |
+245,980
| New | +$10.8M | 0.27% | 136 |
|
Other funds holding ABBV
LMCG Investments's ABBV Position: Q2 2026 in Review
LMCG Investments increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $713K and bringing the position to 139,806 shares worth $35.2M. The position accounts for 1.88% of the portfolio, ranked #9.
LMCG Investments first reported a position in ABBV in Q2 2013 and has held it in 28 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- LMCG Investments held 139,806 shares of AbbVie worth $35.2M as of Q2 2026.
- LMCG Investments bought 3,312 AbbVie shares in Q2 2026, an estimated $713K.
- AbbVie made up 1.88% of LMCG Investments's portfolio in Q2 2026, its #9 holding.
- LMCG Investments first reported a position in AbbVie in Q2 2013 and has held it in 28 quarters since.
- 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on LMCG Investments's 13F filing for Q2 2026, filed 22 Jul 2026.